Alcohol-related liver disease Digestive System
Conditions
Interventions
The community pharmacy alcohol-related liver disease (ArLD) risk identification and linkage to care through development of a complex intervention, or ‘CIPLINC’, study will use the structure of the Med
Sponsors
University of Southampton
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All participants: 1. Age 18 years or over 2. Able to give written consent in English Specific to participant groups: Group 1 - Patients with Alcohol-related liver disease (ArLD) 1. Diagnosis of ArLD 2. Under the care of gastroenterology/hepatology outpatient clinic Group 2 - Community Pharmacy users 1. Attended a community pharmacy at least once in the last year 2. Drink alcohol 3. Offered novel service* 4. Engaging with novel service*# Group 3 - Community Pharmacy staff 1. Currently working in a community pharmacy as pharmacist, pharmacy assistant or pharmacy technician 2. Member of staff in a pharmacy delivering the novel service* Group 4 - Healthcare professional involved in ArLD Care Pathways Currently employed as any of: 1. General Practitioner 2. Primary care nurse practitioner 3. Hepatology consultant 4. Hepatology specialist nurse 5. Alcohol care team worker *only applies to participants being recruited after implementation of the novel service #requirement for participants for telephone surveys only
Exclusion criteria
Exclusion criteria: All participants: 1. Age <18 years 2. Unable to understand written and spoken English to consent for or complete the study 3. Lacking capacity to consent Specific to participant groups: Group 2 Community Pharmacy users 1. Currently working as a member of pharmacy team (pharmacist, pharmacy technician, pharmacy support staff) 2. Current healthcare professional involved in ArLD Care Pathways Group 3 Community Pharmacy staff 1. Member of staff not involved in delivering the novel service* *only applies to participants being recruited after implementation of the novel service
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Pharmacy recruitment rate recorded as the number of eligible pharmacies recruited to deliver the novel service. Timepoint 31/09/2024 2. Acceptability of the novel service to service providers and service users measured using qualitative interviews. Timepoint 31/03/2025 3. Feasibility of implementing the novel service measured by analysis of service use data. Timepoint 31/03/2025 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Number of people assessed in the service measured from service use data. Timepoint 31/03/2025 2. Number of people assessed in the service identified as at risk of alcohol related liver disease measured from service use data. Timepoint 31/03/2025 3. Number of people identified in the service as at risk of alcohol related liver disease connected to alcohol related liver disease pathways of care measured from service use data. Timepoint 31/03/2025 4. Recruitment rate of telephone survey recorded as the number of eligible participants who consent to participate in the telephone survey. Timepoint 31/03/2025 | — |
Countries
England, United Kingdom
Outcome results
None listed